Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI North America CPhI North America
Not Confirmed
Not Confirmed
20-22 May, 2025
World Vaccine Conferen...World Vaccine Conference
Not Confirmed
Not Confirmed
22-24 April, 2025
Not Confirmed
Not Confirmed
22-25 April, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI North America CPhI North America
Industry Trade Show
Not Confirmed
20-22 May, 2025
World Vaccine Conferen...World Vaccine Conference
Industry Trade Show
Not Confirmed
22-24 April, 2025
Industry Trade Show
Not Confirmed
22-25 April, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/how-trump-s-tariffs-on-imported-drugs-can-hurt-supply-chains-consumers-and-industry
02 Jan 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/01/02/3003512/0/en/Carmell-Announces-Execution-of-Definitive-Agreement-to-Acquire-Elevai-Skincare-a-leader-in-Physician-Dispensed-Exosome-Skin-and-Hair-Care-Products.html
29 Jul 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/07/29/2920272/0/en/Carmell-Corporation-Appoints-New-CEO-Following-Addition-to-the-Russell-Microcap-Index.html
12 Sep 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/moonshot-client-axolotl-announces-merger-with-carmell-therapeutics-elevating-the-field-of-regenerative-medicine-301925137.html
05 Sep 2023
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2023/09/05/2737946/0/en/Carmell-Corporation-Announces-Completion-of-Post-Merger-Integration-with-Axolotl-Biologix-and-New-Organizational-Structure-Aligned-with-Focus-on-Aesthetics.html
09 Aug 2023
// BUSINESSWIRE
27 Jul 2023
// BUSINESSWIRE
Details:
Axolotl designs, develops and sells human amnion-based allograft products for active soft tissue repair, aesthetics and orthopedic indications and is also enrolling a Phase I/II trial for Ankle Osteoarthritis and developing a topical cosmeceutical for skin rejuvenation.
Lead Product(s): Axolotl Graft
Therapeutic Area: Trauma (Emergency, Injury, Surgery) Brand Name: Axolotl Graft
Study Phase: Approved FDFProduct Type: Cell and Gene therapy
Sponsor: Carmell Therapeutics
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Merger December 09, 2023
Lead Product(s) : Axolotl Graft
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Carmell Therapeutics
Deal Size : Undisclosed
Deal Type : Merger
Details : Axolotl designs, develops and sells human amnion-based allograft products for active soft tissue repair, aesthetics and orthopedic indications and is also enrolling a Phase I/II trial for Ankle Osteoarthritis and developing a topical cosmeceutical for sk...
Product Name : Axolotl Graft
Product Type : Cell and Gene therapy
Upfront Cash : Undisclosed
December 09, 2023
Details:
Axolotl designs, develops and sells human amnion-based allograft products for active soft tissue repair, aesthetics and orthopedic indications and is also enrolling a Phase I/II trial for Ankle Osteoarthritis and developing a topical cosmeceutical for skin rejuvenation.
Lead Product(s): Axolotl Graft
Therapeutic Area: Trauma (Emergency, Injury, Surgery) Brand Name: Axolotl Graft
Study Phase: Approved FDFProduct Type: Cell and Gene therapy
Sponsor: Carmell Therapeutics
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Merger September 08, 2023
Lead Product(s) : Axolotl Graft
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Carmell Therapeutics
Deal Size : Undisclosed
Deal Type : Merger
Details : Axolotl designs, develops and sells human amnion-based allograft products for active soft tissue repair, aesthetics and orthopedic indications and is also enrolling a Phase I/II trial for Ankle Osteoarthritis and developing a topical cosmeceutical for sk...
Product Name : Axolotl Graft
Product Type : Cell and Gene therapy
Upfront Cash : Undisclosed
September 08, 2023
Details:
Axolotl designs, develops and sells human amnion-based allograft products for active soft tissue repair, aesthetics and orthopedic indications and is also enrolling a Phase I/II trial for Ankle Osteoarthritis and developing a topical cosmeceutical for skin rejuvenation.
Lead Product(s): Axolotl Graft
Therapeutic Area: Trauma (Emergency, Injury, Surgery) Brand Name: Axolotl Graft
Study Phase: Approved FDFProduct Type: Cell and Gene therapy
Sponsor: Carmell Therapeutics
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Merger July 27, 2023
Lead Product(s) : Axolotl Graft
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Carmell Therapeutics
Deal Size : Undisclosed
Deal Type : Merger
Details : Axolotl designs, develops and sells human amnion-based allograft products for active soft tissue repair, aesthetics and orthopedic indications and is also enrolling a Phase I/II trial for Ankle Osteoarthritis and developing a topical cosmeceutical for sk...
Product Name : Axolotl Graft
Product Type : Cell and Gene therapy
Upfront Cash : Undisclosed
July 27, 2023
Details:
Axolotl designs, develops and sells human amnion-based allograft products for active soft tissue repair, aesthetics and orthopedic indications and is also enrolling a Phase I/II trial for Ankle Osteoarthritis and developing a topical cosmeceutical for skin rejuvenation.
Lead Product(s): Axolotl Graft
Therapeutic Area: Trauma (Emergency, Injury, Surgery) Brand Name: Axolotl Graft
Study Phase: Approved FDFProduct Type: Cell and Gene therapy
Sponsor: Carmell Therapeutics
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Merger May 09, 2023
Lead Product(s) : Axolotl Graft
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Carmell Therapeutics
Deal Size : Undisclosed
Deal Type : Merger
Details : Axolotl designs, develops and sells human amnion-based allograft products for active soft tissue repair, aesthetics and orthopedic indications and is also enrolling a Phase I/II trial for Ankle Osteoarthritis and developing a topical cosmeceutical for sk...
Product Name : Axolotl Graft
Product Type : Cell and Gene therapy
Upfront Cash : Undisclosed
May 09, 2023
Details:
Carmell Therapeutics is in early preclinical testing of BHA product as an orthobiolgoic to determine the capability of BHA to act as an enhancer to existing bone graft substitutes as well as a stand-alone new alternative to bone graft substitute products.
Lead Product(s): Undisclosed,Calcium Phosphate
Therapeutic Area: Orthopedics/Orthopedic Surgery Brand Name: Undisclosed
Study Phase: Phase IIProduct Type: Other Large Molecule
Sponsor: Alpha Healthcare Acquisition Corp
Deal Size: $154.0 million Upfront Cash: Undisclosed
Deal Type: Merger April 01, 2023
Lead Product(s) : Undisclosed,Calcium Phosphate
Therapeutic Area : Orthopedics/Orthopedic Surgery
Highest Development Status : Phase II
Partner/Sponsor/Collaborator : Alpha Healthcare Acquisition Corp
Deal Size : $154.0 million
Deal Type : Merger
Details : Carmell Therapeutics is in early preclinical testing of BHA product as an orthobiolgoic to determine the capability of BHA to act as an enhancer to existing bone graft substitutes as well as a stand-alone new alternative to bone graft substitute products...
Product Name : Undisclosed
Product Type : Other Large Molecule
Upfront Cash : Undisclosed
April 01, 2023
Details:
Carmell to begin enrolling in pivotal clinical program for first-of-its-kind Plasma-based Bioactive Material product used in long-bone fractures as an adjunctive treatment.
Lead Product(s): Calcium Phosphate
Therapeutic Area: Orthopedics/Orthopedic Surgery Brand Name: Undisclosed
Study Phase: Phase IIProduct Type: Other Small Molecule
Sponsor: Inapplicable
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable July 01, 2020
Lead Product(s) : Calcium Phosphate
Therapeutic Area : Orthopedics/Orthopedic Surgery
Highest Development Status : Phase II
Partner/Sponsor/Collaborator : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Carmell Therapeutics Receives IND Clearance for CT-101, Bone Healing Accelerant
Details : Carmell to begin enrolling in pivotal clinical program for first-of-its-kind Plasma-based Bioactive Material product used in long-bone fractures as an adjunctive treatment.
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
July 01, 2020
Details:
The Fast Track status offers the company benefits in improving and accelerating the company's trial on Bone Healing Accelerant in open tibia fractures to the target of a Biologic License Application.
Lead Product(s): Calcium Phosphate,Undisclosed
Therapeutic Area: Orthopedics/Orthopedic Surgery Brand Name: Undisclosed
Study Phase: Phase IIProduct Type: Other Small Molecule
Sponsor: Inapplicable
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable April 27, 2020
Lead Product(s) : Calcium Phosphate,Undisclosed
Therapeutic Area : Orthopedics/Orthopedic Surgery
Highest Development Status : Phase II
Partner/Sponsor/Collaborator : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
FDA grants Carmell Therapeutics Expedited Review for CT-101, Bone Healing Accelerant
Details : The Fast Track status offers the company benefits in improving and accelerating the company's trial on Bone Healing Accelerant in open tibia fractures to the target of a Biologic License Application.
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
April 27, 2020
ABOUT THIS PAGE